Erasca, Inc. (ERAS)

6d ago, source: Yahoo Finance

Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript March 29, 2024 Erasca, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details ...

Erasca Announces $45 Million Oversubscribed Private Placement Financing

22d ago, source: Business Insider

SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS) (“Erasca”), a clinical-stage precision oncology company singularly focused on ...

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

22d ago, source: Nasdaq

SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...

Erasca, Inc. (ERAS) Interactive Stock Chart - Yahoo Finance

21d ago, source: Yahoo Finance

Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript March 29, 2024 Erasca, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details ...

Erasca, Inc. (ERAS) R&D Update Call and Q4 2023 Earnings Call Transcript

20d ago, source: Seeking Alpha

Welcome to the Erasca R&D Update conference call. At this time, all participants are in a listen only mode. Following management's prepared remarks, we will hold a brief question and answer ...

Erasca (NASDAQ: ERAS)

10d ago, source: The Motley Fool

Erasca, Inc. is a clinical stage precision oncology company, It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly ...

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

22d ago, source: Business Insider

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven ...

Erasca Inc ERAS

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Erasca Announces $45 Million Oversubscribed Private Placement Financing

22d ago, source: Stockhouse

SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS) (“Erasca”), a clinical-stage precision oncology company singularly focused on discovering, developing, ...

Erasca, Inc. (ERAS) Interactive Stock Chart - Yahoo Finance

21d ago, source: Yahoo Finance

Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript March 29, 2024 Erasca, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here) ...

Erasca, Inc.: Erasca Announces $45 Million Oversubscribed Private Placement Financing

22d ago, source: Finanznachrichten

Zeit Aktuelle Nachrichten 01.04. Erasca, Inc. (ERAS) Q4 2023 Earnings Call Transcript 28.03. Erasca to get $45M funding via private placement 28.03. Erasca, Inc.: Erasca Announces $45 Million ...

Erasca, Inc.: Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

22d ago, source: Finanznachrichten

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven ...